Australia’s penicillin crisis: How a single drug shortage exposes our medical manufacturing vulnerability
When a critical medication that protects Australia’s most vulnerable communities runs short, who pays the price? A new investigation reveals the shocking gaps in our pharmaceutical sovereignty. By Simran Gill. In late February, Australia faced a crisis that few noticed but many felt: a serious shortage of benzathine benzylpenicillin G (BPG), an essential medication used…